109 related articles for article (PubMed ID: 2534360)
1. Characterization of secondary structure of neocarzinostatin apoprotein.
Saito K; Sato Y; Edo K; Akiyama-Murai Y; Koide Y; Ishida N; Mizugaki M
Chem Pharm Bull (Tokyo); 1989 Nov; 37(11):3078-82. PubMed ID: 2534360
[TBL] [Abstract][Full Text] [Related]
2. An antitumor polypeptide antibiotic neocarzinostatin: the mode of apo-protein--chromophore interaction.
Edo K; Saito K; Akiyama-Murai Y; Mizugaki M; Koide Y; Ishida N
J Antibiot (Tokyo); 1988 Apr; 41(4):554-62. PubMed ID: 2967272
[TBL] [Abstract][Full Text] [Related]
3. Neocarzinostatin: carboxyl-terminal-43-peptide residue of apo-neocarzinostatin as the binding site of neocarzinostatin-chromophore.
Edo K; Saito K; Akiyama Y; Mizugaki M; Koide Y; Ishida N
Chem Pharm Bull (Tokyo); 1986 Dec; 34(12):5180-3. PubMed ID: 2952300
[No Abstract] [Full Text] [Related]
4. Neocarzinostatin: selective tryptophan oxidation and neocarzinostatin-chromophore binding to apo-neocarzinostatin.
Edo K; Saito K; Matsuda Y; Akiyama-Murai Y; Mizugaki M; Koide Y; Ishida N
Chem Pharm Bull (Tokyo); 1991 Jan; 39(1):170-6. PubMed ID: 1828722
[TBL] [Abstract][Full Text] [Related]
5. Conformation studies on and assessment by spectral analysis of the protein-chromophore interaction of the macromolecular antitumor antibiotic C-1027.
Otani T
J Antibiot (Tokyo); 1993 May; 46(5):791-802. PubMed ID: 8514634
[TBL] [Abstract][Full Text] [Related]
6. Three-dimensional solution structure of apo-neocarzinostatin.
Gao X
J Mol Biol; 1992 May; 225(1):125-35. PubMed ID: 1533878
[TBL] [Abstract][Full Text] [Related]
7. Design, production, and characterization of recombinant neocarzinostatin apoprotein in Escherichia coli.
Nozaki S; Tomioka Y; Hishinuma T; Inoue M; Nagumo Y; Tsuruta LR; Hayashi K; Matsumoto T; Kato Y; Ishiwata S; Itoh K; Suzuki T; Hirama M; Mizugaki M
J Biochem; 2002 May; 131(5):729-38. PubMed ID: 11983081
[TBL] [Abstract][Full Text] [Related]
8. Conformations of protein moieties and chromophore-protein interactions in the antitumor antibiotics, macromomycin and auromomycin, characterized by IR and CD spectral analysis.
Miwa N
J Antibiot (Tokyo); 1982 Nov; 35(11):1553-60. PubMed ID: 7161194
[TBL] [Abstract][Full Text] [Related]
9. Neocarzinostatin chromophore. Assignment of spectral properties and structural requirements for binding to DNA.
Napier MA; Goldberg IH
Mol Pharmacol; 1983 Mar; 23(2):500-10. PubMed ID: 6220205
[TBL] [Abstract][Full Text] [Related]
10. Key interactions in the immunoglobulin-like structure of apo-neocarzinostatin: evidence from nuclear magnetic resonance relaxation data and molecular dynamics simulations.
Izadi-Pruneyre N; Quiniou E ; Blouquit Y; Perez J; Minard P; Desmadril M; Mispelter J; Adjadj E
Protein Sci; 2001 Nov; 10(11):2228-40. PubMed ID: 11604530
[TBL] [Abstract][Full Text] [Related]
11. Roles of chromophore and apo-protein in neocarzinostatin action.
Kappen LS; Napier MA; Goldberg IH
Proc Natl Acad Sci U S A; 1980 Apr; 77(4):1970-4. PubMed ID: 6445563
[TBL] [Abstract][Full Text] [Related]
12. Stabilization of neocarzinostatin nonprotein chromophore activity by interaction with apoprotein and with HeLa cells.
Kappen LS; Goldberg IH
Biochemistry; 1980 Oct; 19(21):4786-90. PubMed ID: 6448635
[TBL] [Abstract][Full Text] [Related]
13. Production of a free chromophore component of neocarzinostatin (NCS) in the culture filtrate of Streptomyces carzinostaticus var. F-41.
Kudo K; Suto T; Koide Y; Edo K; Ishida N
J Antibiot (Tokyo); 1982 Aug; 35(8):1111-5. PubMed ID: 6216232
[No Abstract] [Full Text] [Related]
14. Unstability of neocarzinostatin-chromophore.
Edo K; Sato H; Saito K; Akiyama Y; Kato M; Mizugaki M; Koide Y; Ishida N
J Antibiot (Tokyo); 1986 Apr; 39(4):535-40. PubMed ID: 2423490
[TBL] [Abstract][Full Text] [Related]
15. [Mechanisms of actions of neocarzinostatin (NCS) and NCS-associated nonprotein chromophore (author's transl)].
Ohtsuki K; Ishida N
Tanpakushitsu Kakusan Koso; 1981 Jun; 26(7):937-49. PubMed ID: 6457319
[No Abstract] [Full Text] [Related]
16. Sequential 1H NMR assignments and secondary structure of aponeocarzinostatin in solution.
Remerowski ML; Glaser SJ; Sieker LC; Samy TS; Drobny GP
Biochemistry; 1990 Sep; 29(36):8401-9. PubMed ID: 2147566
[TBL] [Abstract][Full Text] [Related]
17. Naphthalenecarboxylic acid from neocarzinostatin (NCS).
Edo K; Katamine S; Kitame F; Ishida N; Koide Y; Kusano G; Nozoe S
J Antibiot (Tokyo); 1980 Mar; 33(3):347-51. PubMed ID: 6445890
[No Abstract] [Full Text] [Related]
18. Enzyme immunoassay of neocarzinostatin using beta-galactosidase as label.
Tanimori H; Kitagawa T; Tsunoda T; Tsuchiya R
J Pharmacobiodyn; 1981 Oct; 4(10):812-9. PubMed ID: 6459444
[TBL] [Abstract][Full Text] [Related]
19. Solution structure of a novel chromoprotein derived from apo-neocarzinostatin and a synthetic chromophore.
Urbaniak MD; Muskett FW; Finucane MD; Caddick S; Woolfson DN
Biochemistry; 2002 Oct; 41(39):11731-9. PubMed ID: 12269815
[TBL] [Abstract][Full Text] [Related]
20. Isolation of a non-protein component and a protein component from neocarzinostatin (NCS) and their biological activities.
Koide Y; Ishii F; Hasuda K; Koyama Y; Edo K; Kitamine S; Kitame F; Ishida N
J Antibiot (Tokyo); 1980 Mar; 33(3):342-6. PubMed ID: 6445889
[No Abstract] [Full Text] [Related]
[Next] [New Search]
